Company
United StatesPublic company, NYSE: ABTAbbott Laboratories (NYSE: ABT), Santa Clara, CA – FDA Inspections
Inspection records and compliance data for Abbott Laboratories in Santa Clara, California. 5 FDA inspections on record, last inspected May 17, 2017. Publicly traded as NYSE: ABT.
Company Profile
This profile covers Abbott Laboratories based in Santa Clara, California, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 1
- NAI
- 4
- Form 483s
- 0
- Warning letters
- 0
First inspected August 12, 2009. Last inspected May 17, 2017.
Most cited issue areas
- Design validation - user needs and intended uses1 inspection
- Individual Report of Malfunction1 inspection
- Purchasing controls, Lack of or inadequate procedures1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 17, 2017 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1017182 |
| August 10, 2016 | VAI | Medical Devices & Rad Health · Compliance: Devices | 986276 |
| May 16, 2013 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 834101 |
| April 1, 2011 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 716720 |
| August 12, 2009 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 605426 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Abbott Laboratories
Stock ticker
ABT
Exchange
NYSE
Share price
$113.74
Market cap
$197.0B
Price as of
November 6, 2026
FEI Number
2919069
Address
4551 Great America Pkwy, Santa Clara, California 95054, United States
Country
United States
ID: f6f4f865-d6e2-4434-a4dd-65cb24859877